Jaguar Health Files 2024 10-K, Details Financial Agreements
Ticker: JAGX · Form: 10-K · Filed: 2025-03-31T00:00:00.000Z
Sentiment: neutral
Topics: 10-K, financial-agreements, stock-transactions
TL;DR
Jaguar Health's 2024 10-K is out. Lots of financial agreements and stock stuff from 2022-2024. Check it.
AI Summary
Jaguar Health, Inc. filed its 10-K for the fiscal year ending December 31, 2024. The company, formerly known as Jaguar Animal Health, Inc., is involved in the pharmaceutical preparations industry. Key financial events and agreements mentioned include a Royalty Interest December 2020 Purchase Agreement with Iliad Capital Limited dated April 14, 2022, and a Tempesta Note Payable from 2019. The filing also references equity transactions involving Irving Park Capital LLC and Series I Convertible Preferred Stock during 2023.
Why It Matters
This filing provides a comprehensive overview of Jaguar Health's financial performance and significant agreements for the past fiscal year, which is crucial for investors to assess the company's stability and future prospects.
Risk Assessment
Risk Level: medium — The filing details various financial agreements and stock transactions, indicating potential complexity and ongoing financial activities that could pose risks.
Key Numbers
- 2024-12-31 — Fiscal Year End (The period covered by the 10-K filing.)
- 2025-03-31 — Filing Date (The date the 10-K was submitted to the SEC.)
- 001-36714 — SEC File Number (The SEC's file number for Jaguar Health, Inc.)
Key Players & Entities
- Jaguar Health, Inc. (company) — Filer of the 10-K
- Jaguar Animal Health, Inc. (company) — Former name of the filer
- Iliad Capital Limited (company) — Party to the Royalty Interest December 2020 Purchase Agreement
- Irving Park Capital LLC (company) — Involved in Series I Convertible Preferred Stock transactions
- 2024-12-31 (date) — Fiscal year end for the 10-K report
- 2025-03-31 (date) — Filing date of the 10-K
FAQ
What was the nature of the Royalty Interest December 2020 Purchase Agreement with Iliad Capital Limited?
The filing references a Royalty Interest December 2020 Purchase Agreement with Iliad Capital Limited, dated April 14, 2022, but does not provide specific details of the agreement's terms within the provided text.
What is the significance of the Tempesta Note Payable from 2019?
The Tempesta Note Payable from 2019 is mentioned in the context of the fiscal year 2024, indicating it was an outstanding financial obligation during this period, though specific terms are not detailed.
What role did Irving Park Capital LLC play in Jaguar Health's financial activities?
Irving Park Capital LLC is associated with Series I Convertible Preferred Stock transactions that occurred between January 1, 2023, and December 31, 2023.
When did Jaguar Health, Inc. change its name from Jaguar Animal Health, Inc.?
The company's name change from Jaguar Animal Health, Inc. to Jaguar Health, Inc. occurred on August 30, 2013.
Are there any subsequent events disclosed in the filing as of March 26, 2025?
Yes, the filing indicates a subsequent event on March 26, 2025, related to a Securities Purchase Agreement involving Warrant Shares, but specific details are not provided in the excerpt.
From the Filing
0000950170-25-047184.txt : 20250331 0000950170-25-047184.hdr.sgml : 20250331 20250331064531 ACCESSION NUMBER: 0000950170-25-047184 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 120 CONFORMED PERIOD OF REPORT: 20241231 FILED AS OF DATE: 20250331 DATE AS OF CHANGE: 20250331 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Jaguar Health, Inc. CENTRAL INDEX KEY: 0001585608 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36714 FILM NUMBER: 25788753 BUSINESS ADDRESS: STREET 1: 200 PINE STREET SUITE 400 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 415-371-8300 MAIL ADDRESS: STREET 1: 200 PINE STREET SUITE 400 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 FORMER COMPANY: FORMER CONFORMED NAME: Jaguar Animal Health, Inc. DATE OF NAME CHANGE: 20130830 10-K 1 jagx-20241231.htm 10-K 10-K false 0001585608 FY ten days 3 P1Y P1Y Five year 0.0167 0.04 http://fasb.org/srt/2024#ChiefFinancialOfficerMember 0.04 0001585608 2023-12-31 0001585608 jagx:EmployeeAndNonEmployeeStockOptionAndRsusMember 2024-01-01 2024-12-31 0001585608 jagx:RoyaltyInterestDecember2020PurchaseAgreementMember jagx:IliadCapitalLimitedMember 2022-04-14 0001585608 jagx:TempestaNotePayableTwoThousandNineteenMember 2024-01-01 2024-12-31 0001585608 us-gaap:CommonStockMember jagx:IrvingParkCapitalLlcMember jagx:SeriesIConvertiblePreferredStockMember 2023-01-01 2023-12-31 0001585608 2024-10-01 2024-12-31 0001585608 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-12-31 0001585608 jagx:AldAutomativeItaliaSRLMember jagx:LeasedVehicleMember 2022-05-31 0001585608 jagx:NotInsiderMember jagx:SecuritiesPurchaseAgreementMember jagx:WarrantSharesMember us-gaap:SubsequentEventMember 2025-03-26 0001585608 jagx:ParticipantsVotingPowerMoreThanTenPercentMember jagx:EquityIncentivePlan2014Member 2015-05-12 2015-05-12 0001585608 us-gaap:SalesRevenueNetMember jagx:TwoMajorPharmaceuticalDistributorsMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001585608 jagx:StreetervilleNoteAmendmentMember us-gaap:SubsequentEventMember 2025-02-13 2025-02-13 0001585608 jagx:AtMarketOfferingMember us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-12-31 0001585608 jagx:StandstillAgreementMember jagx:IliadWarrantsMember 2023-05-08 0001585608 us-gaap:NonvotingCommonStockMember 2025-03-31 0001585608 jagx:StreetervilleNoteMember 2024-12-31 0001585608 jagx:GlobalAmendmentNo2ToRoyaltyInterestOctober2020PurchaseAgreementMember jagx:StreetervilleWarrantsMember 2024-01-01 2024-12-31 0001585608 jagx:MasterServicesAgreementWithIntegriumLlc2020Member 2023-12-31 0001585608 us-gaap:FairValueInputsLevel3Member srt:WeightedAverageMember us-gaap:MeasurementInputDiscountRateMember 2023-12-31 0001585608 srt:MaximumMember jagx:StreetervilleNoteMember 2021-01-13 2021-01-13 0001585608 us-gaap:FairValueInputsLevel3Member jagx:StreetervilleRoyaltyInterestMember 2024-12-31 0001585608 jagx:StockholderRightsPlanMember us-gaap:SubsequentEventMember 2025-02-26 2025-02-26 0001585608 jagx:NotInsiderMember jagx:SecuritiesPurchaseAgreementMember us-gaap:SubsequentEventMember 2025-03-26 0001585608 us-gaap:SalesRevenueNetMember srt:MinimumMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-12-31 0001585608 jagx:March2021PurchaseAgreementMember jagx:BeginningOnOctober2021Member 2021-03-08 2021-03-08 0001585608 us-gaap:LandMember 2024-12-31 0001585608 jagx:SeriesIConvertiblePreferredStockMember 2023-09-29 2023-09-29 0001585608 jagx:MytesiMember jagx:SpecialtyPharmaciesMember 2023-01-01 2023-12-31 0001585608 us-gaap:FairValueInputsLevel3Member srt:WeightedAverageMember us-gaap:MeasurementInputDiscountRateMember 2024-12-31 0001585608 srt:MinimumMember jagx:CopernicoCentraleAgreementMember jagx:LeasedOfficePremisesSuite600Member 2023-10-25 0001585608 jagx:EmployeeAndNonEmployeeStockOptionAndRsusMember 2022-12-31